Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
The University of Alabama at Birmingham (UAB) Health System and Humana have signed an agreement to expand Humana's Medicare Advantage provider network in Alabama. This allows Humana Medicare Advantage members in Alabama to access various UAB and affiliated facilities, including UAB Hospital, UAB Hospital-Highlands, UAB Callahan Eye Hospital & Clinics, UAB Medical West, and UAB Medicine Outpatient Clinics.
According to Matt Berger, President of Humana's Gulf South Region, this partnership aims to offer high-quality healthcare options to Humana members, helping them achieve and maintain their best health. The agreement, effective earlier this year, aims to enhance the healthcare experience for Medicare Advantage members in Alabama.
Humana is committed to providing quality healthcare services to a diverse range of customers, including those on Medicare and Medicaid, through its insurance services and CenterWell healthcare services.
CenterWell Specialty Pharmacy has been awarded the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the sixth time in seven years, reflecting high patient satisfaction and commitment to personalized care. This award is based on net promoter scores from patient satisfaction surveys. CenterWell provides comprehensive care for chronic and complex illnesses, including 24-hour pharmacist access and specialized treatment guidance. The pharmacy also aids patients in applying for assistance programs to reduce the cost of specialty medications.
Humana (NYSE: HUM) has advanced to 6th place on Fair360's list of Top 50 Companies for Workplace Fairness, up from 10th last year. This marks its seventh consecutive year in the top rankings.
Humana's achievements in 2023 include nearly 100% of senior leaders completing cultural competency development, 22% of BIPOC talent in Director+ roles, and 50% of women in Director+ roles. The company has also made significant investments, such as $360 million with diverse suppliers and $160 million to philanthropic causes.
Humana remains dedicated to diversity, equity, and inclusion, emphasizing mentorship and sponsorship programs and aiming to foster a culture where all employees feel valued and empowered.
Humana announced that Jim Rechtin will become President and CEO on July 1, 2024, succeeding Bruce Broussard. Rechtin joined Humana in January as President and COO, working closely with Broussard. Broussard will step down from the Board but remain a strategic advisor until 2026. Rechtin will join the Board effective July 1, 2024.
Rechtin brings over 22 years of healthcare experience, previously serving as CEO of Envision Healthcare and holding roles at OptumCare and DaVita Medical Group. He aims to drive growth and improve operations, focusing on equitable, high-quality healthcare and long-term shareholder value.
Humana Inc. (NYSE: HUM) will be presenting at B of A Securities Health Care Conference on May 14, 2024. The presentation by CEO Bruce D. Broussard and CFO Susan M. Diamond will be available via live audio webcast on Humana's Investor Relations page. Humana focuses on putting health first for its customers, offering insurance and health care services to improve quality of life for various demographics.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
